William Edgar Carson

View Scopus Profile

Phone614-293-6306
EmailWilliam.Carsonosumcedu

h-index

Research activity per year

257 Article
25 Review article
6 Comment/debate
3 Conference contribution
More

6 results

Filter

2018
Erratum: Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4⁺ T cells in cancer and measurement of STAT1 nitration (Scientific reports (2017) 7 1 (15424))
Markowitz, J., Wang, J., Vangundy, Z., You, J., Yildiz, V., Yu, L., Foote, I. P., Branson, O. E., Stiff, A. R., Brooks, T. R., Biesiadecki, B., Olencki, T., Tridandapani, S., Freitas, M. A., Papenfuss, T., Phelps, M. A. & Carson, W. E., Mar 6 2018, In: Scientific Reports. 8, 1, p. 4203 1 p., 4203.
Research output: Contribution to journal › Comment/debate

Open Access
2015

ASCO 2015 update on melanoma
Carson, W. E., Dec 1 2015, In: Surgical Oncology. 24, 4, p. 363-365 3 p.
Research output: Contribution to journal › Comment/debate

4 Scopus citations
2013

Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. Oncoimmunology 2012; 1:1048-60
Foy, K. C., Miller, M. J., Moldovan, N., Carson, W. E. & Kaumaya, P. P. T., Jan 2013, In: OncoImmunology. 2, 1, e23914.
Research output: Contribution to journal › Comment/debate

Open Access
2011
Defining the critical hurdles in cancer immunotherapy
Fox, B. A., Schendel, D. J., Butterfield, L. H., Aamdal, S., Allison, J. P., Ascierto, P. A., Atkins, M. B., Bartunkova, J., Bergmann, L., Berinstein, N., Bonorino, C. C., Borden, E., Bramson, J. L., Britten, C. M., Cao, X., Carson, W. E., Chang, A. E., Characiejus, D., Raja Choudhury, A. & Coukos, G. & 85 others, de Gruijl, T., Dillman, R. O., Dolstra, H., Dranoff, G., Durrant, L. G., Finke, J. H., Galon, J., Gollob, J. A., Gouttefangeas, C., Grizzi, F., Guida, M., Håkansson, L., Hege, K., Herberman, R. B., Stephen Hodi, F., Hoos, A., Huber, C., Hwu, P., Imai, K., Jaffee, E. M., Janetzki, S., June, C. H., Kalinski, P., Kaufman, H. L., Kawakami, K., Kawakami, Y., Keilholtz, U., Khleif, S. N., Kiessling, R., Kotlan, B., Kroemer, G., Lapointe, R., Levitsky, H. I., Lotze, M. T., Maccalli, C., Maio, M., Marschner, J. P., Mastrangelo, M. J., Masucci, G., Melero, I., Melief, C., Murphy, W. J., Nelson, B., Nicolini, A., Nishimura, M. I., Odunsi, K., Ohashi, P. S., O'Donnell-Tormey, J., Old, L. J., Ottensmeier, C., Papamichail, M., Parmiani, G., Pawelec, G., Proietti, E., Qin, S., Rees, R., Ribas, A., Ridolfi, R., Ritter, G., Rivoltini, L., Romero, P. J., Salem, M. L., Scheper, R. J., Seliger, B., Sharma, P., Shiku, H., Singh-Jasuja, H., Song, W., Straten, P. T., Tahara, H., Tian, Z., van der Burg, S. H., von Hoegen, P., Wang, E., Welters, M. J. P., Winter, H., Withington, T., Wolchok, J. D., Xiao, W., Zitvogel, L., Zwierzina, H., Marincola, F. M., Gajewski, T. F., Wigginton, J. M. & Disis, M. L., Dec 14 2011, In: Journal of Translational Medicine. 9, 1, 214.
Research output: Contribution to journal › Comment/debate

Open Access
142 Scopus citations
NK cell-based immunotherapy for treating cancer: Will it be promising?
Cho, D., Kim, S. K. & Carson, W. E., Mar 2011, In: Korean Journal of Hematology. 46, 1, p. 3-5 3 p.
Research output: Contribution to journal › Comment/debate

Open Access

22 Scopus citations
2010
Braking bad: Blockade of inhibitory pathways improves interleukin-15 therapy
Carson, W. E., Dec 15 2010, In: Clinical Cancer Research. 16, 24, p. 5917-5919 3 p.
Research output: Contribution to journal › Comment/debate
1 Scopus citations

William Edgar Carson

Research output

Search results

Erratum: Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration (Scientific reports (2017) 7 1 (15424))

ASCO 2015 update on melanoma

Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. Oncoimmunology 2012; 1:1048-60

Defining the critical hurdles in cancer immunotherapy

NK cell-based immunotherapy for treating cancer: Will it be promising?

Braking bad: Blockade of inhibitory pathways improves interleukin-15 therapy

Erratum: Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4⁺ T cells in cancer and measurement of STAT1 nitration (Scientific reports (2017) 7 1 (15424))